Patents by Inventor Frédéric Leroy
Frédéric Leroy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200162017Abstract: A photovoltaic panel is provided, including a plastic support sheet having a cellular core; a laminate of photovoltaic cells fixed to the support sheet; and a plastic and/or composite frame including longitudinal profile sections for laterally protecting the laminate of photovoltaic cells and the support sheet, and corner-shaped portions connecting the longitudinal profile sections together in order therewith to form a closed frame.Type: ApplicationFiled: June 28, 2018Publication date: May 21, 2020Applicant: TOTAL SOLARInventors: Valerick CASSAGNE, Jean Guillaume LOBJOIS, Frederic LEROY
-
Patent number: 9284307Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.Type: GrantFiled: August 4, 2010Date of Patent: March 15, 2016Assignee: Idenix Pharmaceuticals LLCInventors: Christophe Claude Parsy, Francois-Rene Alexandre, Frederic Leroy, Thierry Convard, Dominique Surleraux
-
Patent number: 9186369Abstract: This invention is directed to a method for treating a host, especially a human, infected with hepatitis C, flavivirus and/or pestivirus, comprising administering to that host an effective amount of an anti-HCV biologically active pentofuranonucleoside where the pentofuranonucleoside base is an optionally substituted 2-azapurine. The optionally substituted pentofuranonucleoside, or a salt or prodrug thereof, may be administered alone or in combination with one or more optionally substituted pentofuranonucleosides or other anti-viral agents.Type: GrantFiled: May 2, 2014Date of Patent: November 17, 2015Assignee: Idenix Pharmaceuticals, LLCInventors: Richard Storer, Gilles Gosselin, David Dukhan, Frederic Leroy
-
Patent number: 8993595Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.Type: GrantFiled: January 10, 2013Date of Patent: March 31, 2015Assignee: Idenix Pharmaceuticals, Inc.Inventors: Christophe Claude Parsy, Francois-Rene Alexandre, Michel Derock, Frederic Leroy, Jean-Christophe Meillon, Thierry Convard, Dominique Surleraux
-
Publication number: 20140234251Abstract: This invention is directed to a method for treating a host, especially a human, infected with hepatitis C, flavivirus and/or pestivirus, comprising administering to that host an effective amount of an anti-HCV biologically active pentofuranonucleoside where the pentofuranonucleoside base is an optionally substituted 2-azapurine. The optionally substituted pentofuranonucleoside, or a salt or prodrug thereof, may be administered alone or in combination with one or more optionally substituted pentofuranonucleosides or other anti-viral agents.Type: ApplicationFiled: May 2, 2014Publication date: August 21, 2014Applicants: Indenix Pharmaceuticals, Inc., The Centre National de la Recherche Scientifique, L'Universite Montpellier IIInventors: Richard STORER, Gilles GOSSELIN, David DUKHAN, Frederic LEROY
-
Patent number: 8742101Abstract: This invention is directed to a method for treating a host, especially a human, infected with hepatitis C, flavivirus and/or pestivirus, comprising administering to that host an effective amount of an anti-HCV biologically active pentofuranonucleoside where the pentofuranonucleoside base is an optionally substituted 2-azapurine. The optionally substituted pentofuranonucleoside, or a salt or prodrug thereof, may be administered alone or in combination with one or more optionally substituted pentofuranonucleosides or other anti-viral agents.Type: GrantFiled: November 13, 2008Date of Patent: June 3, 2014Assignees: Idenix Pharmaceuticals, Inc., Centre National de la Recherche Scientifique, L'Universite Montpellier IIInventors: Richard Storer, Gilles Gosselin, David Dukhan, Frederic Leroy
-
Patent number: 8697548Abstract: A method for making a semi-conductor nanocrystals, including at least the steps of: making a stack of at least one uniaxially stressed semi-conductor thin layer and a dielectric layer, annealing the semi-conductor thin layer such that a dewetting of the semi-conductor forms, on the dielectric layer, elongated shaped semi-conductor nanocrystals oriented perpendicularly to the stress axis.Type: GrantFiled: May 4, 2012Date of Patent: April 15, 2014Assignees: Commissariat a l'energie atomique et aux energies alternatives, Centre National de la Recherche ScientifiqueInventors: Lukasz Borowik, Jean-Charles Barbe, Ezra Bussmann, Fabien Cheynis, Frédéric Leroy, Denis Mariolle, Pierre Müller
-
Patent number: 8647957Abstract: A method for making semi-conductor nanocrystals, including at least the steps of: forming solid carbon chemical species on a semi-conductor thin layer provided on at least one dielectric layer, the dimensions and the density of the carbon chemical species formed on the semi-conductor thin layer being a function of the desired dimensions and density of the semi-conductor nanocrystals; annealing the semi-conductor thin layer, performing a dewetting of the semi-conductor and forming, on the dielectric layer, the semi-conductor nanocrystals.Type: GrantFiled: May 4, 2012Date of Patent: February 11, 2014Assignees: Commissariat à l'énergie atomique et aux énergies alternatives, Centre National de la Recherche ScientifiqueInventors: Lukasz Borowik, Jean-Charles Barbe, Ezra Bussmann, Fabien Cheynis, Frederic Leroy, Denis Mariolle, Pierre Muller
-
Patent number: 8609076Abstract: The present invention relates to the use of polyols of formula (I): or a salt thereof, for preventing the hair from breaking. The invention also relates to a cosmetic composition comprising at least one such polyol or a salt thereof, in a cosmetically acceptable medium, and also to a cosmetic hair treatment process using the said composition.Type: GrantFiled: May 13, 2005Date of Patent: December 17, 2013Assignee: L'OrealInventors: Frederic Leroy, Michel Philippe, Philippe Barbarat, Christian Blaise
-
Patent number: 8377962Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.Type: GrantFiled: April 7, 2010Date of Patent: February 19, 2013Assignee: Idenix Pharmaceuticals, Inc.Inventors: Christophe Claude Parsy, Francois-Rene Alexandre, Michel Derock, Frederic Leroy, Jean-Christophe Meillon, Thierry Convard, Dominique Surleraux
-
Patent number: 8379015Abstract: The invention relates to a method of generating a synthesized image of a hair, comprising the following steps: calculating the shape of the hair by applying a behavioral relationship determining the shape of the hair as a function of a physical parameter linked to a mechanical property of the hair, in particular the linear density; producing an image of the hair of shape that has been calculated in this way.Type: GrantFiled: April 29, 2011Date of Patent: February 19, 2013Assignee: Centre National de la Recherche ScientifiqueInventors: Jean-Luc Leveque, Basile Audoly, Frederic Leroy, Bernard Querleux
-
Publication number: 20120282758Abstract: A method for making semi-conductor nanocrystals, including at least the steps of: forming solid carbon chemical species on a semi-conductor thin layer provided on at least one dielectric layer, the dimensions and the density of the carbon chemical species formed on the semi-conductor thin layer being a function of the desired dimensions and density of the semi-conductor nanocrystals; annealing the semi-conductor thin layer, performing a dewetting of the semi-conductor and forming, on the dielectric layer, the semi-conductor nanocrystals.Type: ApplicationFiled: May 4, 2012Publication date: November 8, 2012Applicants: Centre National De La Recherche Scientifique, Commissariat a L'Energie Atomique Et Aux Ene AltInventors: Lukasz BOROWIK, Jean-Charles Barbe, Ezra Bussmann, Fabien Cheynis, Frédéric Leroy, Denis Mariolle, Pierre Müller
-
Publication number: 20120282759Abstract: A method for making a semi-conductor nanocrystals, including at least the steps of: making a stack of at least one uniaxially stressed semi-conductor thin layer and a dielectric layer, annealing the semi-conductor thin layer such that a dewetting of the semi-conductor forms, on the dielectric layer, elongated shaped semi-conductor nanocrystals oriented perpendicularly to the stress axis.Type: ApplicationFiled: May 4, 2012Publication date: November 8, 2012Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENE ALTInventors: Lukasz BOROWIK, Jean-Charles BARBE, Ezra BUSSMANN, Fabien CHEYNIS, Frédéric LEROY, Denis MARIOLLE, Pierre Müller
-
Patent number: 8193372Abstract: Provided herein are phosphothiophene and phosphothiazole compounds, for example, of any of Formulae I, IA, IIA, IIIA, IVA, VA, VIA, VIIA, IB, IIB, IIIB, IVB, VB, VIB and VIIB disclosed herein, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host infected with HCV.Type: GrantFiled: March 3, 2010Date of Patent: June 5, 2012Assignee: Idenix Pharmaceuticals, Inc.Inventors: Cyril Dousson, Claire Pierra, Jean-Francois Griffon, Frederic Leroy, Jean-Laurent Paparin, David Dukhan, Dominique Surleraux
-
Patent number: 8026911Abstract: The invention relates to a method of generating a synthesized image of a hair, comprising the following steps: calculating the shape of the hair by applying a behavioral relationship determining the shape of the hair as a function of a physical parameter linked to a mechanical property of the hair, in particular the linear density; producing an image of the hair of shape that has been calculated in this way.Type: GrantFiled: March 19, 2007Date of Patent: September 27, 2011Assignee: L'OrealInventors: Jean-Luc Leveque, Basile Audoly, Frederic Leroy, Bernard Querleux
-
Publication number: 20110205225Abstract: The invention relates to a method of generating a synthesized image of a hair, comprising the following steps: calculating the shape of the hair by applying a behavioral relationship determining the shape of the hair as a function of a physical parameter linked to a mechanical property of the hair, in particular the linear density; producing an image of the hair of shape that has been calculated in this way.Type: ApplicationFiled: April 29, 2011Publication date: August 25, 2011Applicant: L'OrealInventors: Jean-Luc Leveque, Basile Audoly, Frederic Leroy, Bernard Querleux
-
Patent number: 8003659Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.Type: GrantFiled: February 3, 2009Date of Patent: August 23, 2011Assignee: Indenix Pharmaceuticals, Inc.Inventors: Christophe Claude Parsy, Francois-Rene Alexandre, Dominique Surleraux, Michel Derock, Frederic Leroy
-
Publication number: 20110129443Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.Type: ApplicationFiled: August 4, 2010Publication date: June 2, 2011Applicant: Idenix Pharmaceuticals, Inc.Inventors: Christophe Claude Parsy, Francois-Rene Alexandre, Frederic Leroy, Thierry Convard, Dominique Surleraux
-
Publication number: 20100260710Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.Type: ApplicationFiled: April 7, 2010Publication date: October 14, 2010Applicant: Idenix Pharmaceuticals, Inc.Inventors: Christophe Claude Parsy, Francois-Rene Alexandre, Michel Derock, Frederic Leroy, Jean-Christophe Meillon, Thierry Convard, Dominique Surleraux
-
Publication number: 20100233123Abstract: Provided herein are phosphothiophene and phosphothiazole compounds, for example, of any of Formulae I, IA, IIA, IIIA, IVA, VA, VIA, VIIA, IB, IIB, IIIB, IVB, VB, VIIB and VIIB disclosed herein, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host infected with HCV.Type: ApplicationFiled: March 3, 2010Publication date: September 16, 2010Applicant: Idenix Pharmaceuticals, Inc.Inventors: Cyril Dousson, Claire Pierra, Jean-Francois Griffon, Frederic Leroy, Jean-Laurent Paparin, David Dukhan, Dominique Surleraux